NLRP3 and pemphigus foliaceus: In contrast, therapeutics targeting the NLRP3 inflammasome represent a novel approach that directly addresses the inflammatory cascade at its source, potentially offering more comprehensive control of both the inflammatory and fibrotic processes in PF.